Cytosorbents Corp

Nasdaq:CTSO

Surgical & Medical Instruments & Apparatus·PRINCETON, NJ

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

CEO

Chan Phillip P.

CFO

Mariani Peter J

Summary Financials

Revenue

$1.8M

+4917.4% YoY

FY 2018

Adj. EBITDA

-$30.5M

-1684.3% margin

FY 2024

Net Income

-$29.2M

-1615.7% margin

FY 2024

EPS (Diluted)

-$0.17

FY 2024

Stock Price

$0.71

-2.5%

2026-03-13

52W Range

$0.60 – $1.39

P/E Ratio

-4.2x

Market Cap

$44.4M

Cash

$14.1M

FY 2024

Total Debt

$2.5M

FY 2024

Net Cash

$11.6M

FY 2024

Enterprise Value

$32.9M

Debt / EBITDA

0.4x

FY 2018

EV / EBITDA

-1.1x

Employees

—

CytoSorbents Corporation is a publicly traded company located in Princeton, New Jersey.

CEO

Chan Phillip P.

CFO

Mariani Peter J

Revenue

$1.8M

+4917.4% YoY

FY 2018

Adj. EBITDA

-$30.5M

-1684.3% margin

FY 2024

Net Income

-$29.2M

-1615.7% margin

FY 2024

EPS (Diluted)

-$0.17

FY 2024

Stock Price

$0.71

-2.5%

2026-03-13

52W Range

$0.60 – $1.39

P/E Ratio

-4.2x

Market Cap

$44.4M

Cash

$14.1M

FY 2024

Total Debt

$2.5M

FY 2024

Net Cash

$11.6M

FY 2024

Enterprise Value

$32.9M

Debt / EBITDA

0.4x

FY 2018

EV / EBITDA

-1.1x

Employees

—